Celldex Therapeutics inc (CLDX) Annual Balance Sheets

Annual · GAAP · USD millions
Access CLDX quarterly Balance Sheets →
The table below presents a historical view of Celldex Therapeutics inc's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent28.87
Combined Cash+Investments Total (filer-reported)518.60
Marketable Securities, Current SH489.70
Cash & Short-term Investments517.00
Accounts receivable2.02
Prepaid Expense And Other Assets Current14.08
Total Current Assets534.66
Equipment/Property/Plant Net5.33
Intangible Assets27.19
Other Assets, Noncurrent15.80
Operating Lease Right Of Use Asset2.44
Total Assets582.98
Liabilities
Accounts Payable, Current AC1.18
Accrued Liabilities, Current AC47.03
Other Liabilities, Current2.78
Total Current Liabilities50.99
Total Long-term Debt0.00
Other liabilities, Noncurrent4.83
Operating Lease Liability Current1.55
Operating Lease Liability Noncurrent0.78
Total Liabilities55.82
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock2,337.45
Retained Earnings / Accumulated Deficit-1,813.98
Other Equity3.63
Common Stockholder's Equity527.17
Total Stockholder's Equity527.17
Liabilities & Stockholder's Equity582.98
4 historic quarters locked

Sign in to unlock the full Celldex Therapeutics inc balance sheet history.

About Celldex Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-019652

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.